May 29 – June 2, 2026

ASCO Annual Meeting 2026

Chicago, IL
UBC is proud to participate in the ASCO Annual Meeting, the world’s leading oncology conference bringing together clinicians, researchers, and industry experts to advance cancer care. This event provides a global platform for sharing innovations in clinical research, evidence generation, and patient safety strategies.

UBC partners with sponsors to deliver integrated solutions that combine real-world evidence development and risk management programs to support oncology therapies throughout the product lifecycle. Our expertise ensures regulatory compliance, patient safety, and actionable insights for informed decision-making.

  • Evidence Development Solutions: Registries, observational studies, and real-world data strategies to support oncology research and market access.
  • Integrated Approach: Linking evidence generation with safety operations for end-to-end program support.
  • Safety & Risk Management: REMS program design and implementation, risk minimization strategies, and global compliance.
  • Oncology Expertise: Proven experience supporting complex oncology programs across diverse therapeutic areas.

Connect with UBC at the ASCO Annual Meeting to learn how our EDS and SRM solutions can support your oncology programs.
UBC Pinwheel logo

Schedule a Meeting

Learn More About UBC

We are dedicated to uniting evidence and access for biopharma. Fill out the form to get in touch with our team and learn more.

Other Events

Scenic view of San Diego with palm trees and boats
Trade show
RSVP

Outsourcing in Clinical Trials Southern California 2026

Meet UBC at OCT SoCal to discuss evidence development solutions that generate meaningful real‑world insights for clinical and post‑market programs.
Aerial view of the downtown San Diego, California with the famed convention center as the focal point.
Trade show
RSVP

HUB and Specialty Pharmacy West Conference 2026

UBC is looking forward to engaging with industry partners at HUB and Specialty Pharmacy West 2026 to discuss patient access strategies that improve affordability, verification, and adherence support.
View of the Boston Seaport District near the Boston Convention Center
Trade show
RSVP

World Orphan Drug Congress 2026

Meet UBC at the World Orphan Drug Congress USA, the leading event for rare disease therapies and orphan drug development. Explore solutions for evidence generation, safety, and patient access.

Schedule a Meeting

UBC logo white

Thank You for Connecting with UBC

Lorem ipsum dolor sit amet consectetur. Mi proin enim ipsum nascetur. Venenatis odio scelerisque non netus ac et pellentesque.

What You Can Expect Next

Lorem ipsum dolor sit amet consectetur. Cras aliquam erat eget magna sollicitudin.

UBC logo white

Get Ready to Change Your Business

Lorem ipsum dolor sit amet consectetur. Mi proin enim ipsum nascetur. Venenatis odio scelerisque non netus ac et pellentesque.

Service Request

Bekki Bracken Brown Headshot

Bekki Bracken Brown

President & Chief Executive Officer

Bekki Bracken Brown serves as the President and CEO of UBC, guiding the company’s mission and values, including the improvement of access for patients to receive better outcomes. She oversees all aspects of UBC, such as operations, business growth strategy, sales and marketing, and acquisition support.

With over 20 years of industry experience, Ms. Brown brings knowledge from a successful career in senior management from her tenure at Quintiles, INC Research, and, most recently, with Syneos Health. She’s been a member of the North Carolina BIO Board of Directors since 2019. She is also a member of the Healthcare Businesswomen’s Association — Southeast Chapter and CHIEF, an organization that supports women executive leaders. Ms. Brown earned her bachelor’s degree at Duke University.